Send us a text

In this episode of the GLP-1 Hub podcast, host Ana Reisdorf and guest Dana Fryer discuss the use of GLP-1 medications in oncology patients, focusing on weight management, nutrition education, and the challenges faced by patients undergoing cancer treatment. They explore the spectrum of patient experiences with GLP-1, the importance of protein in the diet, and the barriers related to insurance coverage for these medications. The conversation also highlights the unique nutritional needs of cancer survivors and the future of GLP-1 in cancer treatment.

About Dana: 

Dana J. Fryer, MS, RDN, CNSC, is a Boston-based Registered Dietitian Nutritionist and the owner of Dana J. Fryer Nutrition LLC. She holds a Master's degree in Nutrition from Boston University and completed her clinical training at Boston Medical Center. Dana specializes in weight management, oncology, and chronic disease prevention and management. In addition to her clinical practice, she tutors dietetic students preparing for the registered dietitian exam and hosts the "Dietetics with Dana" podcast.

Website: https://danajfnutrition.com

Instagram: @danajfnutrition

Visit our GLP-1 Hub store:

https://www.glp-1hub.com

Get our FREE 7-day meal plans for GLP-1:

7-Day Meal Plan

Plant-based 7-Day Meal Plan

Want to connect more with GLP-1 Hub?

Instagram: https://www.instagram.com/glp1hub

Tiktok: https://www.tiktok.com/@glp1hub

YouTube: https://www.youtube.com/@glp-1hub

Weekly newsletter with weight loss tips and podcast updates: https://glp1hub.myflodesk.com/rn9j3lxjpp

*Some of the links shared are affiliate links. When you make a purchase, I will receive a small commission at no cost to you. Thank you for supporting the show.

*The content of this show is for informational purposes only and does not constitute medical advice. The goal of this show is to provide various points of view about GLP-1 Medications. The personal and professional opinion of the guests and their content does not necessarily reflect the opinion of Ana Reisdorf or GLP-1 Hub.